测量头癌的财务毒性:系统性审查
Elisa Raggini1,2, Davide Mattavelli1,2, Gabriele Zigliani1
1Unit of Otorhinolaryngology - Head and Neck Surgery, ASST Spedali Civili di Brescia, Brescia, Italy.
概括
金融毒性 (FT) 显著影响头癌患者,在COVID时代成本上升. 财务咨询和成本透明度是减轻这一负担的关键.
科学领域:
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
- 患者支持 患者支持
背景情况:
- 金融毒性 (FT) 对头癌 (HNC) 患者来说是一个重大挑战.
- 与其他癌症疗法相比,HNC治疗往往需要更高的成本.
研究的目的:
- 系统地审查有关头癌患者金融毒性的现有文献.
- 确定有效的策略来缓解金融毒性.
主要方法:
- 使用PubMed,Scopus和Web of Science数据库进行了系统的文献审查.
- 包括的研究是2000年至2022年间发表的全文英语论文,报告了HNC幸存者的定量FT数据.
主要成果:
- 分析了27篇文章,主要是2015年以后发表的,来自美国.
- 口腔癌,状细胞癌和局部发达的HNC是常见的主题. 经过验证的调查问卷 (例如,COST,FIT,FDQ) 测量了FT.
- 金融毒性得分在COVID时代恶化. 财务咨询和明确的成本信息被确定为有效的缓解策略.
结论:
- 在HNC护理中,FT是一个新兴和实质性的问题.
- 需要一种通用FT评估方法和标准化的问卷指南.
- 实施这些措施可以帮助缓解FT并改善患者的治疗结果.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
1.8K
相关概念视频
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
